About AFNET
COOPERATION
Previous cooperation
with sponsors and partners
As a research network AFNET thrives through its cooperation. In the AFNET studies and projects scientists and physicians cooperate on a national, European and sometimes international level.
AFNET was funded by the Federal Ministry of Research and Education (BMBF) from 2003 to 2010. The BMBF provided substantial funding to create the basis for a Germany-wide research network.
Since 2015, AFNET has been closely cooperating with the German Centre of Cardiovascular Research. Within the scope of the strategic partnership, AFNET and DZHK support each other in the conduct of their studies.
In addition, AFNET is in cooperation with various research institutions, e.g. the cardiology societies DGK (German Society of Cardiology), ESC (European Society of Cardiology), EHRA (European Heart Rhythm Association) as well as the German Heart Foundation.
Most AFNET studies involve external partners providing financial support for the conduct of the study. These partners include pharmaceutical and medical device companies, companies providing mobile health, health insurance and players in the public health system.
AFNET is always open to new research cooperations. Institutions, companies and scientists are welcome to approach us with research ideas and project proposals. If you are interested in a cooperation with AFNET, please contact us at info@kompetenznetz-vorhofflimmern.de
Prof. Paulus Kirchhof, Chairman of the Board of AFNET: „We have been continuously funded by public funders. The first 10 years were shaped by funding from the German government, the German Ministry of Education and Research (BMBF), a large grant that enabled the first projects and established the infrastructure. Thereafter we have been continuously funded by the European Union and by other public funders and many of our projects are done as investigator-initiated trials in close cooperation with industry partners. These partners provide the means for us to deliver our projects, and they are partners, but AFNET is in the driving seat.“
PUBLIC PARTNERS & SPONSORS
PRIVATE SECTOR PARTNERS & SPONSORS
SUPPORTING MEMBERS
Apoplex Medical Technologies GmbH
apoplex medical technologies GmbH was founded in Pirmasens in 2004 and specialised as a service provider focusing on new and innovative applications for stroke prevention.
SRA (Stroke Risk Analysis) is used to detect paroxysmal atrial fibrillation. SRAclinic for the identification of atrial fibrillation in stroke units. SRAdoc and SRA24 as screening applications for general practitioners.
apoplex medical technologies GmbH is supported by an extensive academic and clinical network.
Boehringer Ingelheim
The Boehringer Ingelheim Group is one of the world’s top 20 pharmaceutical companies. Based in Ingelheim, Germany, Boehringer Ingelheim is represented worldwide by 145 associated companies and employs more than 44,000 people. Founded in 1885, the family-owned company focuses on the research, development, production and marketing of new medicines with high therapeutic benefit for human medicine and animal health.